Cempra (CEMP) announces its intention to launch a public offering. The proceeds from the...
Cempra (CEMP) announces its intention to launch a public offering. The proceeds from the potential deal will go towards the "Phase 3 clinical trial of solithromycin in community acquired bacterial pneumonia." In a separate PR, CEMP described the steps it will need to take to get the treatment approved.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs